ROBO vs XBI
ROBO Global Robotics and Automation Index ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.95% for ROBO.
- • ROBO pays a higher dividend yield (0.36%).
Side-by-side metrics
| Metric | ROBO | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.95% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.36% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $1.77B | $8.30B |
YTD return | 22.09% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.70 | 1.09 |
P/E ratio | 33.67 | — |
Last price | $83.81 | $133.66 |
Inception | — | — |
Issuer | ROBO Global | State Street |
ROBO top holdings
| CELT | Celtic Investment Inc | 2.22% |
| 1590.TW | Airtac International Group | 1.93% |
| 098460.KQ | Koh Young Technology Inc | 1.85% |
| TER | Teradyne Inc | 1.84% |
| IFX.DE | Infineon Technologies AG | 1.84% |
| 2049.TW | Hiwin Technologies Corp | 1.82% |
| 6324.T | Harmonic Drive Systems Inc | 1.79% |
| 6954.T | Fanuc Corp | 1.78% |
| AMBA | Ambarella Inc | 1.77% |
| 2308.TW | Delta Electronics Inc | 1.76% |
XBI top holdings
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
About ROBO
ROBO (ROBO Global Robotics and Automation Index ETF) is Robotics and automation companies worldwide. Managed by ROBO Global, the fund carries $1.8B in assets under management, an expense ratio of 0.95%, a dividend yield of 0.36%. Its largest holding is Celtic Investment Inc (CELT), which represents 2.2% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 3.1%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.